Home・Aktien・Moderna Inc

Moderna Inc

Geschlossen

BrancheGesundheitswesen

56.94 3.32

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

55.11

Max

58.19

Schlüsselkennzahlen
By Trading Economics
Einkommen	561M -782M
Verkäufe	-244M 145M
EPS	-1.97
Gewinnspanne	-539.31
Angestellte	4,700
EBITDA	554M -704M

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	-11.28% downside

Dividenden
By Acuity
Nächstes Ergebnis	5. Nov. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-194M 22B
Vorheriger Eröffnungskurs	53.62
Vorheriger Schlusskurs	56.94

Nachrichtenstimmung

By Acuity

29%

71%

110 / 340 Ranking in Healthcare

Moderna Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

Moderna Inc Prognose

Kursziel

By TipRanks

-11.28% Nachteil

12-Monats-Prognose

Durchschnitt 48.92 USD -11.28%

Hoch 77 USD

Tief 39 USD

Basierend auf 15 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Moderna Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

15 ratings

Buy

Halten

Sell

Basierend auf 15 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Moderna Inc – Dist abgegeben haben.

Stimmung

By Acuity

110 / 340 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Moderna Inc

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.